This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. It is often employed in the development of pharmaceuticals targeting neurological disorders, particularly those involving the modulation of neurotransmitter systems. The compound's structure, featuring a nicotinate moiety and an oxazoline ring, makes it a valuable building block for creating ligands that interact with specific receptors in the brain. Additionally, it is explored in the design of potential therapeutic agents for conditions like Parkinson's disease and Alzheimer's disease due to its ability to influence dopaminergic and cholinergic pathways. Its application extends to research in organic synthesis, where it serves as a precursor for more complex molecules with potential pharmacological properties.